FC can also be used to identify the expression of targets for potential antibody-directed therapy and provide additional prognostic information such as CD38 and ZAP-70 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) [6]. Here, CD38 is linked to B-cell chronic lymphocytic leukemia.